Development and characterization of sublingual tablet of Lisinopril (cas 76547-98-3)
-
Add time:07/17/2019 Source:sciencedirect.com
ObjectiveLisinopril is the drug of choice in hypertension. Bioavailability of the drug is 25% of orally administered dose. An attempt was made to provide safe medicine meeting pharmacokinetics requirement of plasma concentration by formulating a sublingual tablet of Lisinopril. The Objective of present study is to develop the sublingual tablet of Lisinopril and improve its bioavailability, in view to maximize therapeutic effect of the drug.
We also recommend Trading Suppliers and Manufacturers of Lisinopril (cas 76547-98-3). Pls Click Website Link as below: cas 76547-98-3 suppliers
Prev:Daily Lisinopril (cas 76547-98-3) vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial
Next:Fast and sensitive LC–MS/MS method for the simultaneous determination of Lisinopril (cas 76547-98-3) and hydrochlorothiazide in human plasma) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of Lisinopril (cas 76547-98-3) vs. perindopril: A cohort study07/19/2019
- Fast and sensitive LC–MS/MS method for the simultaneous determination of Lisinopril (cas 76547-98-3) and hydrochlorothiazide in human plasma07/18/2019
- Daily Lisinopril (cas 76547-98-3) vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial07/16/2019
- The cough reflex is upregulated by Lisinopril (cas 76547-98-3) microinjected into the caudal nucleus tractus solitarii of the rabbit07/15/2019
- An innovative validated spectrofluorimetric method for determination of Lisinopril (cas 76547-98-3) in presence of hydrochlorothiazide; application to content uniformity testing07/14/2019
- Effect of amlodipine, Lisinopril (cas 76547-98-3) and allopurinol on acetaminophen-induced hepatotoxicity in rats07/13/2019
- Lisinopril (cas 76547-98-3) inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis07/12/2019
- Randomized Trial of Lisinopril (cas 76547-98-3) Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer07/11/2019